Last reviewed · How we verify
PIB 0.2% ropivacaine — Competitive Intelligence Brief
marketed
Local anesthetic (amide class)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
PIB 0.2% ropivacaine (PIB 0.2% ropivacaine) — University Health Network, Toronto. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PIB 0.2% ropivacaine TARGET | PIB 0.2% ropivacaine | University Health Network, Toronto | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels | |
| Levobupivacaine without epinephrine | Levobupivacaine without epinephrine | Pontificia Universidad Catolica de Chile | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| bupivacaine 0.25 % injection | bupivacaine 0.25 % injection | Ain Shams University | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels | |
| Bupivacaine 0.167% | Bupivacaine 0.167% | Bozyaka Training and Research Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Intravenous Lidocaine | Intravenous Lidocaine | Khon Kaen University | marketed | Local anesthetic; antiarrhythmic agent | Voltage-gated sodium channels | |
| Bupivacaine (Hyperbaric 0.5%) | Bupivacaine (Hyperbaric 0.5%) | Guy's and St Thomas' NHS Foundation Trust | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Paravertebral block using local anesthetic | Paravertebral block using local anesthetic | University of Wisconsin, Madison | marketed | Local anesthetic regional nerve block | Voltage-gated sodium channels (non-selective) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide class) class)
- Ain Shams University · 2 drugs in this class
- Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
- TriHealth Inc. · 2 drugs in this class
- Centre of Postgraduate Medical Education · 2 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Clinique Saint-Jean, Bruxelles · 1 drug in this class
- Hospital Clínico Universitario de Valencia · 1 drug in this class
- Fundacion Clinica Valle del Lili · 1 drug in this class
- Federal University of Minas Gerais · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PIB 0.2% ropivacaine CI watch — RSS
- PIB 0.2% ropivacaine CI watch — Atom
- PIB 0.2% ropivacaine CI watch — JSON
- PIB 0.2% ropivacaine alone — RSS
- Whole Local anesthetic (amide class) class — RSS
Cite this brief
Drug Landscape (2026). PIB 0.2% ropivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/pib-0-2-ropivacaine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab